Cited by 223Atherosclerosis and Cardiovascular DiseasesCancer-related molecular mechanisms researchCardiovascular, Neuropeptides, and Oxidative Stress Research

Smooth Muscle Enriched Long Noncoding RNA ( SMILR ) Regulates Cell Proliferation

Open access
Ballantyne, Margaret D., Pinel, Karine, Dakin, Rachel, Vesey, Alex T., Diver, Louise, Mackenzie, Ruth, Garcia, Raquel, Welsh, Paul +9 more·2016·Circulation

Abstract

Background—: Phenotypic switching of vascular smooth muscle cells from a contractile to a synthetic state is implicated in diverse vascular pathologies, including atherogenesis, plaque stabilization, and neointimal hyperplasia. However, very little is known about the role of long noncoding RNA (lncRNA) during this process. Here, we investigated a role for lncRNAs in vascular smooth muscle cell biology and pathology. Methods and Results—: Using RNA sequencing, we identified >300 lncRNAs whose expression was altered in human saphenous vein vascular smooth muscle cells following stimulation with interleukin-1α and platelet-derived growth factor. We focused on a novel lncRNA (Ensembl: RP11-94A24.1), which we termed smooth muscle–induced lncRNA enhances replication ( SMILR ). Following stimulation, SMILR expression was increased in both the nucleus and cytoplasm, and was detected in conditioned media. Furthermore, knockdown of SMILR markedly reduced cell proliferation. Mechanistically, we noted that expression of genes proximal to SMILR was also altered by interleukin-1α/platelet-derived growth factor treatment, and HAS2 expression was reduced by SMILR knockdown. In human samples, we observed increased expression of SMILR in unstable atherosclerotic plaques and detected increased levels in plasma from patients with high plasma C-reactive protein. Conclusions—: These results identify SMILR as a driver of vascular smooth muscle cell proliferation and suggest that modulation of SMILR may be a novel therapeutic strategy to reduce vascular pathologies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.115.021019

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Non-coding RNAs also control VSMC plasticity, evidenced by the effect of specific miRNAs and long non-coding RNAs on VSMC biology and function.

    “Non-coding RNAs also control VSMC plasticity 235,236 evidenced by the effect of specific miRNAs and long non-coding RNAs on VSMC biology and function 237,238 .”

    From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [238]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [14]Jiang Y Wang HY Cao HM Wang CY Zhang L Wang H Liu L Li Y Cai JH. Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep 2014 4 PMC4052773 24848278
  2. [51]Du Y Gao C Liu Z Wang L Liu B He F Zhang T Wang Y Wang X Xu M Luo GZ Zhu Y Xu Q Wang X Kong W. Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. Arterioscler Thromb Vasc Biol 2012 32 2580 2588 doi: 10.1161/ATVBAHA.112.300206. 22995515 · DOI

Cited by

Sorted by citations

Authors
Ballantyne, M. D., Pinel, K., Dakin, R., Vesey, A. T., Diver, L., Mackenzie, R., Garcia, R., Welsh, P., Sattar, N., Hamilton, G., Joshi, N., Dweck, M. R., Miano, J. M., McBride, M. W., Newby, D. E., McDonald, R. A., & Baker, A. H.
Affiliations
  • University of Rochester Medicine (US)
  • From BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (M.D.B., R.D., L.D., R.M., R.G., P.W., N.S., M.W.N., R.A.M., A.H.B.); British Heart Foundation/University of Edinburgh Centre for Cardiovascular Science, Edinburgh, United Kingdom (M.D.B., K.P., A.T.V., N.J., M.R.D., D.E.N., R.A.M., A.H.B.); Glasgow Polyomics, College of Medical, Veterinary and Life Sciences, The University of Glasgow, United Kingdom (G.H.); and Aab Cardiovascular Research Institute, University of...
Corresponding author
Baker, Andrew H.
Venue
Circulation
Published
2016-05-24
Volume
133
Issue
21
Pages
2050-2065
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2315863900
Cited by
223
References
59
Citations by year
2026: 9 · 2025: 13 · 2024: 19 · 2023: 15 · 2022: 23 · 2021: 24 · 2020: 32 · 2019: 32 · 2018: 37 · 2017: 13 · 2016: 6
FWCI
17.75
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Circulation (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • UCrea (University of Cantabria) (submittedVersion, cc-by)
Funders
  • Wellcome Trust
  • NHS Health Scotland
  • British Heart Foundation (FS/12/66/30003, FS/13/77/30488, RG/09/005/27915, FS/14/78/31020, PG/12/8/29371, RG/14/3/30706)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
Keywords
long non-coding RNA, vascular smooth muscle cells, cell proliferation, phenotypic switching, atherosclerosis, plaque vulnerability, interleukin-1 alpha, platelet-derived growth factor, HAS2, C-reactive protein, intimal hyperplasia
MeSH terms
Cells, Cultured, Humans, Muscle, Smooth, Vascular, Saphenous Vein, Caenorhabditis elegans Proteins, Myocytes, Smooth Muscle, Cell Proliferation, Gene Knockdown Techniques, RNA, Long Noncoding

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review